Sponsored by: The University of Texas Health Science Center, Houston. The purpose of this study is to see if BCC excluding the scalp and face can be treated successfully with a combination therapy of Intron[R]-A and Aldara[R].
Condition Intervention Phase
Basal Cell Carcinoma Biological: Imiquimod Phase IV
Excluding Scalp and Interferon alpha
and Face
Study ID Numbers: HSC-MS-06-0478, OSP-24412
ClinicalTrials.gov Identifier: NCT00581425
COPYRIGHT 2008 Journal of Drugs in Dermatology, Inc. flonase.
COPYRIGHT 2008 Gale, Cengage Learning